Amantadine

Amantadine

SCHEMBL40713

Cl.NC12CC3CC(CC(C3)C1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BM

The experimentally established mechanism targets of Amantadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 known ✓ Q05586 6/20 0.93
GRIN2A known ✓ Q12879 6/20 0.93
GRIN2D known ✓ O15399 5/20 0.93
GRIN3B known ✓ O60391 5/20 0.93
GRIN2B known ✓ Q13224 5/20 0.93
GRIN2C known ✓ Q14957 5/20 0.93
GRIN3A known ✓ Q8TCU5 5/20 0.93
LMNA P02545 4/20 1.00
THRB P10828 2/20 1.00
PMP22 Q01453 2/20 1.00
POLB P06746 1/20 1.00
BLM P54132 1/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
SLC22A1 O15245 2/20 0.93
NFKB1 P19838 2/20 0.93
SLC22A2 O15244 2/20 0.93
SLC47A1 Q96FL8 2/20 0.93
TSHR P16473 1/20 0.93
STAT6 P42226 1/20 0.93
SIGMAR1 Q99720 1/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amantadine SCHEMBL20136303 1.00 LMNA (1.00) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL28543969 0.97 LMNA (0.93) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL29227879 0.97 LMNA (0.93) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL4098 0.96 GRIN1 (1.00) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL20409394 0.96 GRIN1 (1.00) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL3642447 0.96 GRIN1 (1.00) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL15532073 0.96 GRIN1 (1.00) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL21310017 0.96 GRIN1 (1.00) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL21309814 0.96 GRIN1 (1.00) LMNATHRBPMP22POLBBLM
Amantadine SCHEMBL15672299 0.96 GRIN1 (1.00) LMNATHRBPMP22POLBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12409 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139860-A1 PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS CENTRE FOR DIGESTIVE DISEASES (AU) 2026-05-21 US claimed
CN-122036494-A Synthesis method and application of amantadine-butylphthalide eutectic 佛山大学 2026-05-15 CN claimed
CN-122010742-A Continuous flow synthesis method of amantadine hydrochloride 沈阳化工研究院有限公司 2026-05-12 CN claimed
CN-121570438-A Sustained and controlled release preparation process and formula of compound paracetamol and amantadine hydrochloride capsules 海南亚洲制药股份有限公司 2026-02-27 CN claimed
WO-2026043843-A1 TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2026-02-26 WO claimed
EP-4680248-A1 PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM Topelia Aust Limited (ACN 652 771 670) (AU) 2026-01-21 EP claimed
US-20250387315-A1 Dental Varnishes Based On Cationic Polymer Dispersions IVOCLAR VIVADENT AG (LI) 2025-12-25 US claimed
US-20250382291-A1 SUBSTITUTED PYRROLO[2,3-b]PYRIDINES FOR SUPPRESSING TOXIC ENDOPLASMIC RETICULUM STRESS UNIV COLUMBIA (US) 2025-12-18 US claimed
US-12473656-B2 Gold-copper alloy nanostructure and method for synthesizing the same CITY UNIVERSITY OF HONG KONG (HK) 2025-11-18 US claimed
US-20250269005-A1 METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT TOPELIA AUST LIMITED (ACN 652 771 670) (AU) 2025-08-28 US claimed
US-5175002-A Amantadine hydrochloride syspension with enhanced dissolution characteristics for use in soft gelatin capsules DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-12-29 US claimed
US-5157151-A Salts of 1-adamantamine and formulations thereof ANGRES ISAAC (US) 1992-10-20 US claimed
EP-0473844-A1 Medicament containing a combination of AZT and amantadin for the treatment of AIDS Lange, Werner, Prof. (DE) 1992-03-11 EP claimed
WO-1992000066-A1 AMANTADINE HYDROCHLORIDE SUSPENSION WITH ENHANCED DISSOLUTION CHARACTERISTICS FOR USE IN SOFT GELATIN CAPSULES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-01-09 WO claimed
EP-0316345-A1 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE LIPOSOME TECHNOLOGY, INC. (US) 1989-05-24 EP claimed
EP-0316345-A4 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE. LIPOSOME TECHNOLOGY INC (US) 1989-05-16 EP claimed
WO-1988000824-A1 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE LIPOSOME TECHNOLOGY, INC. (US) 1988-02-11 WO claimed
EP-0003827-B1 ANTIDEPRESSANT COMBINATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-10 EP claimed
EP-0003827-A1 Antidepressant combination E.I. DU PONT DE NEMOURS AND COMPANY (US) 1979-09-05 EP claimed
US-4148896-A AMANTADINE AND MOLINDONE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1979-04-10 US claimed